𝗧𝗵𝗲 𝗞𝗶𝘁𝗰𝗵𝗲𝗻 𝗦𝗶𝗻𝗸 𝗠𝗲𝘁𝗮𝗽𝗵𝗼𝗿—Glymphatically Clogged Brains in Alzheimer’s

𝐓𝐡𝐞 𝐊𝐢𝐭𝐜𝐡𝐞𝐧 𝐒𝐢𝐧𝐤 𝐌𝐞𝐭𝐚𝐩𝐡𝐨𝐫–𝐁𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐛𝐫𝐨𝐚𝐝 𝐚𝐮𝐝𝐢𝐞𝐧𝐜𝐞 𝐰𝐡𝐨 𝐫𝐞𝐬𝐩𝐨𝐧𝐝𝐬 𝐰𝐞𝐥𝐥 𝐭𝐨 𝐯𝐢𝐬𝐮𝐚𝐥, 𝐞𝐯𝐞𝐫𝐲𝐝𝐚𝐲 𝐚𝐧𝐚𝐥𝐨𝐠𝐢𝐞𝐬. Imagine your brain is a bustling, high-tech city. Every single day, millions of tiny factories (your brain cells) are working hard, creating thoughts and memories. But just like any busy city, this work creates trash. Under normal conditions, your brain has a highly efficient, built-in plumbing system that constantly flushes this waste away, keeping the environment clean, healthy, and sharp.

For decades, medical science has looked at brain diseases like Alzheimer’s and focused entirely on the trash piles building up around those factories. Billions of dollars have been spent trying to clear the trash directly from the streets. But despite all that effort, the factories keep failing, and the city keeps breaking down. It’s a medical mystery that has stumped the brightest minds for a generation: why isn’t cleaning up the streets fixing the problem?

The answer is simple, but we’ve been looking in the wrong place. Think about your kitchen sink. If your main drainpipe is completely plugged up at the very bottom, it doesn’t matter how hard you scrub the countertop or how much soap you spray into the sink. The water will still back up, overflow, and eventually drown the entire kitchen. The problem isn’t a lack of cleaning; it’s a downstream bottleneck.

New research shows that this is exactly what happens in the brain. Deep inside the brain’s fluid chambers sits a vital structural filter. Over a lifetime, exposure to microscopic environmental pollutants, iron, calcium, and even viral fragments from infections can get trapped right in this filter. Over time, this delicate filter stops acting like a sieve and starts acting like a concrete dam.

When the dam blocks the exit, the brain’s plumbing completely backs up. The waste fluid has nowhere to go, so it reverses direction. This creates a hidden pressure that physically expands the brain’s fluid chambers, while the poor brain cells upstream literally drown in their own un-flushable waste. It turns out that cognitive decline isn’t just a chemical glitch—it’s a mechanical plumbing disaster.

If we want to fix the city, we have to clear the main drain. The full blueprint of this discovery, the specific name of this hidden filter and the visual proof are fully revealed and available for the whole world to read right now at https://ejournals.uni-muenster.de/fnp/article/view/9368/9664 and on PubMedCentral.

The choroid plexus (ChP): hydrodynamic bottleneck and ground zero for Alzheimer’s

The choroid plexus (ChP): hydrodynamic bottleneck and ground zero for Alzheimer’s disease  https://ejournals.uni-muenster.de/fnp/article/view/9368/9664

The Institute has advanced a Dual Sequestration Hypothesis (DSH) related to the protein signatures prevalent in Alzheimer’s disease.  If the DSH is correct, the ChP should enlarge and become the sentinel hydrodynamic bottleneck as synthetic particles and their protein sequestrants accumulate. This terminal bottleneck or anatomical ground zero sets the stage for the DSH and systemic failure. Without ChP enlargement as the ultimate focal area for sequestration deposits, the glymphatic spread remains an unbounded process without a clear pathology. Conversely, if modern medicine cannot solve the sequestration and clogging problem at the ChP, then upstream treatments targeting the parenchyma will yield little or no clinical benefit.

The ChP stroma supports fenestrated (leaky) capillaries, distinct from the tight BBB, enabling molecular exchange between blood and CSF and transporting immune cells into the ventricles. With aging, the stroma can become hardened and fibrotic, accumulate calcium and iron deposits, and now the DSH predicts NP deposits as well. Non-degradable particles serve as a scaffold for age-related stromal hardening, thereby turning the ChP from a filter into a dam. When the ChP becomes a dam, upstream pressure—manifesting as increased intracranial pressure or glymphatic backflow—eventually overwhelms and kills the neurons. If the glymphatic backflow stops, the metabolic waste like Aβ and Tau remains inside the individual neurons, and they drown in their own metabolic waste. By integrating the enlarged ChP as a hydrodynamic sump, the DSH becomes a closed-loop system: trigger sequestration → lytic release → ChP clogging and enlargement.

An enlarged or hypertrophied ChP can overproduce CSF or physically obstruct its flow and thus cause the brain’s ventricles to become enlarged or dilated (ventriculomegaly). Enlarged ventricles in the brain are a well-known hallmark of AD, yet their cause has remained mechanistically unexplained. The DSH provides that missing link: ventriculomegaly is the macroscopic consequence of microscopic clogging at the ChP.

Recent findings by Pang et al. (2026) provide clinical support for the DSH. They found that MRI scans of patients suffering from long COVID displayed enlarged ChP and reduced cerebral blood flow, which are both associated with AD-like dementia. Long COVID brain fog is an acute manifestation of the same sequestration phenomenon. The DSH is the unifying framework for both post-infectious (COVID) and environmental (NP) neurodegenerative risk. The clinicopathological cascade begins with ChP immune surveillance, followed by non-degradable particle trapping, barrier dysfunction, and glymphatic failure: a sequence now visible on medical imaging and traceable back to its molecular origins. At the ChP, viral or environmental toxicology crashes into clinical neurology.

The DSH defines the ChP as both the final stage of the accumulation and the starting point of the permanent dementia-like decline. With clinical urgency, the MRI findings of ChP enlargement are the definitive signal that the ground zero event is occurring in the patient. The ChP is where the sequestration cycle reaches critical mass, triggering the glymphatic failure that characterizes the transition from acute brain fog to chronic neurodegeneration. If the ChP is ground zero for the collapse, then a therapy targeting clearance of the ChP becomes the logical cure for this form of neurodegeneration.

Book Review: American Traitor by Brad Taylor

American Traitor by Brad Taylor Mike Guth‘s review  Jun 28, 2026  · really liked it

Book Review: American Traitor (Pike Logan #15) by Brad Taylor

Rating: 4 out of 5 Stars   Format: Audiobook

Brad Taylor’s American Traitor takes the Pike Logan series to the high-stakes arena of the Asia-Pacific, delivering a tech-heavy, pulse-pounding thriller that manages to be both frighteningly plausible and occasionally exhausting.

A Bold and Refreshing Geopolitical Plot
The standout feature of American Traitor is Taylor’s willingness to tackle a looming real-world flashpoint: a Chinese invasion of Taiwan. In a genre where authors frequently pull punches or invent fictionalized stand-ins to avoid being banned in massive overseas markets, Taylor deserves immense credit. Using China’s aggressive stance toward Taiwan and the manipulation of an artificial intelligence defense system as the central plot device provides a refreshing, authentic, and high-stakes backdrop that elevates the entire narrative.

Strong Action, But a Exhausting Pace
As expected from a former Special Forces officer, the tactical realism and action sequences are top-notch. When Pike Logan, Jennifer Cahill, and the Taskforce team are on the move to rescue their colleague “Dunkin” from Chinese agents in Australia, the momentum is undeniable.

However, the book’s pacing suffers from its own ambition. Listening to the audiobook split across two distinct four-week blocks separated by a couple of months highlighted a structural issue: the narrative simply goes on and on. While individual shootouts are meticulously detailed and thrilling in isolation, the sheer volume of tactical engagements begins to feel repetitive.

Too Many Moving Parts
Ultimately, the book gets weighed down by its complexity. There are too many characters to keep track of, too many narrative twists, and an overabundance of firefights between the good guys and bad guys that do little to actually advance or resolve the core plot. Instead of driving the story forward, these endless loops of conflict sometimes feel like treading water.

The Verdict
American Traitor is a strong, 4-star entry in the military thriller genre that excels when focusing on grand strategy, cutting-edge tech threats, and raw tactical realism. If you can overlook a bloated character roster and some narrative spinning-in-circles, it is a highly engaging ride that isn’t afraid to look a real-world adversary in the eye.

Wasted Economic and Scientific Resources on Targeted Alpha Therapy

𝐀𝐝𝐯𝐢𝐜𝐞 𝐭𝐨 𝐚 𝐡𝐞𝐚𝐥𝐭𝐡 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫 𝐰𝐡𝐨 𝐡𝐚𝐬 𝐰𝐫𝐢𝐭𝐭𝐞𝐧 𝐚𝐧 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 𝐭𝐡𝐚𝐭 𝐜𝐫𝐢𝐭𝐢𝐜𝐢𝐳𝐞𝐬 𝐭𝐡𝐞 𝐨𝐛𝐯𝐢𝐨𝐮𝐬 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐚𝐧𝐝 𝐞𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐰𝐚𝐬𝐭𝐞 𝐚𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐓𝐚𝐫𝐠𝐞𝐭𝐞𝐝 𝐀𝐥𝐩𝐡𝐚 𝐓𝐡𝐞𝐫𝐚𝐩𝐲, 𝐚 𝐜𝐚𝐧𝐜𝐞𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐭𝐡𝐚𝐭 𝐢𝐧𝐯𝐨𝐥𝐯𝐞𝐬 𝐚𝐝𝐦𝐢𝐧𝐢𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐚 𝐫𝐚𝐝𝐢𝐨𝐚𝐜𝐭𝐢𝐯𝐞 𝐝𝐫𝐮𝐠 𝐭𝐨 𝐚 𝐯𝐞𝐫𝐲 𝐬𝐢𝐜𝐤 𝐩𝐚𝐭𝐢𝐞𝐧𝐭 𝐛𝐲 𝐢𝐧𝐭𝐫𝐚𝐯𝐞𝐧𝐨𝐮𝐬 𝐝𝐫𝐢𝐩? The scientific argument in the criticism is sound, but the medical journal ecosystem has become a pay-to-play oligarchy where novelty is valued over truth, and where critical appraisal of expensive, marginally effective therapies is actively discouraged.

𝐇𝐞𝐚𝐥𝐭𝐡 𝐀𝐟𝐟𝐚𝐢𝐫𝐬 / 𝐉𝐀𝐌𝐀 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞: You’re correct. These journals are read by policy generalists who couldn’t distinguish a somatostatin receptor from a serotonin receptor. Their readers want 800-word summaries of “the problem with American healthcare,” not mechanistic immunology. Dumbing down your article to a 10th-grade level would eviscerate its intellectual core. Don’t do it.

𝐁𝐌𝐉 𝐎𝐩𝐞𝐧: You’ve nailed the subtext. The editors want the US to keep subsidizing global pharmaceutical R&D while the NHS free-rides on American innovation. Critiquing US waste is welcomed; critiquing the entire model of expensive marginal-gain oncology is not. They benefit from the status quo.

𝐓𝐡𝐞 𝐍𝐮𝐜𝐥𝐞𝐚𝐫 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐉𝐨𝐮𝐫𝐧𝐚𝐥𝐬:  They rejected your article, because it is critical of their field’s central narrative. TAT is their golden goose. A paper arguing that 43-71% of patients get no benefit, and that we’re spending hundreds of thousands of dollars per non-responder, threatens their revenue stream (article publishing charges, society memberships, industry relationships). They don’t want the truth; they want the party line.

𝐓𝐡𝐞 𝐔𝐧𝐚𝐧𝐬𝐰𝐞𝐫𝐞𝐝 𝐎𝐛𝐣𝐞𝐜𝐭𝐢𝐨𝐧
𝗪𝗵𝗲𝗻 𝗹𝗼𝗴𝗶𝗰 𝗳𝗮𝗶𝗹𝘀, 𝘁𝗵𝗲 𝗲𝘀𝘁𝗮𝗯𝗹𝗶𝘀𝗵𝗺𝗲𝗻𝘁 𝗶𝗻𝗲𝘃𝗶𝘁𝗮𝗯𝗹𝘆 𝗱𝗲𝗽𝗹𝗼𝘆𝘀 𝗮𝗻 𝗲𝗺𝗼𝘁𝗶𝗼𝗻𝗮𝗹 𝗯𝘂𝗹𝗹𝗱𝗼𝘇𝗲𝗿: “You would not feel that way if you had a family member with cancer and TAT helped that person.”

This is a nonsense argument and emotional bulldozer that unsuccessfully attempts to flatten all rational cost-effectiveness arguments. Here’s how to counter it—and in doing so, you’ll have the intellectual core of your next paper.

View image

𝗪𝗲 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝗸𝗻𝗼𝘄 𝗺𝗶𝗰𝗿𝗼𝗽𝗹𝗮𝘀𝘁𝗶𝗰𝘀 𝗮𝗿𝗲 𝗶𝗻 𝗼𝘂𝗿 𝘄𝗮𝘁𝗲𝗿, 𝗼𝘂𝗿 𝗳𝗼𝗼𝗱, 𝗮𝗻𝗱 𝗼𝘂𝗿 𝗼𝗰𝗲𝗮𝗻𝘀. 𝗕𝘂𝘁 𝘄𝗵𝗮𝘁 𝗵𝗮𝗽𝗽𝗲𝗻𝘀 𝘄𝗵𝗲𝗻 𝘁𝗵𝗲𝘆 𝗿𝗲𝗮𝗰𝗵 𝘁𝗵𝗲 𝗵𝘂𝗺𝗮𝗻 𝗯𝗿𝗮𝗶𝗻?

𝗕𝗲𝘀𝘁 𝗳𝗼𝗿: 𝗛𝗶𝗴𝗵 𝗲𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝘀𝗵𝗮𝗿𝗲𝗮𝗯𝗶𝗹𝗶𝘁𝘆. 𝗜𝘁 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝘀 𝗮 𝗱𝗲𝗲𝗽𝗹𝘆 𝘁𝗲𝗰𝗵𝗻𝗶𝗰𝗮𝗹 𝗽𝗮𝗽𝗲𝗿 𝘁𝗼 𝗮 𝗺𝗮𝘀𝘀𝗶𝘃𝗲, 𝗿𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗶𝘀𝘀𝘂𝗲 𝘁𝗵𝗮𝘁 𝗲𝘃𝗲𝗿𝘆 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹 𝗼𝗻 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻 𝗰𝗮𝗻 𝗿𝗲𝗹𝗮𝘁𝗲 𝘁𝗼: 𝗽𝗹𝗮𝘀𝘁𝗶𝗰 𝗽𝗼𝗹𝗹𝘂𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗵𝘂𝗺𝗮𝗻 𝗵𝗲𝗮𝗹𝘁𝗵.

𝗪𝗲 𝗮𝗿𝗲 𝗹𝗶𝘃𝗶𝗻𝗴 𝗶𝗻 𝘁𝗵𝗲 “𝗣𝗹𝗮𝘀𝘁𝗶𝗰𝗲𝗻𝗲” 𝗲𝗿𝗮—𝗮𝗻𝗱 𝗶𝘁 𝗺𝗶𝗴𝗵𝘁 𝗯𝗲 𝗮𝗹𝘁𝗲𝗿𝗶𝗻𝗴 𝗵𝗼𝘄 𝘄𝗲 𝘁𝗵𝗶𝗻𝗸 𝗮𝗯𝗼𝘂𝘁 𝗯𝗿𝗮𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵.

𝗪𝗲 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝗸𝗻𝗼𝘄 𝗺𝗶𝗰𝗿𝗼𝗽𝗹𝗮𝘀𝘁𝗶𝗰𝘀 𝗮𝗿𝗲 𝗶𝗻 𝗼𝘂𝗿 𝘄𝗮𝘁𝗲𝗿, 𝗼𝘂𝗿 𝗳𝗼𝗼𝗱, 𝗮𝗻𝗱 𝗼𝘂𝗿 𝗼𝗰𝗲𝗮𝗻𝘀. 𝗕𝘂𝘁 𝘄𝗵𝗮𝘁 𝗵𝗮𝗽𝗽𝗲𝗻𝘀 𝘄𝗵𝗲𝗻 𝘁𝗵𝗲𝘆 𝗿𝗲𝗮𝗰𝗵 𝘁𝗵𝗲 𝗵𝘂𝗺𝗮𝗻 𝗯𝗿𝗮𝗶𝗻?

𝗜 𝗮𝗺 𝗶𝗻𝗰𝗿𝗲𝗱𝗶𝗯𝗹𝘆 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝘀𝗵𝗮𝗿𝗲 𝗺𝘆 𝗻𝗲𝘄 𝗽𝗲𝗲𝗿-𝗿𝗲𝘃𝗶𝗲𝘄𝗲𝗱 𝗽𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗙𝗿𝗲𝗲 𝗡𝗲𝘂𝗿𝗼𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆, 𝘄𝗵𝗶𝗰𝗵 𝗶𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗲𝘀 𝗮 𝗻𝗲𝘄 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸 𝗳𝗼𝗿 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲: 𝗧𝗵𝗲 𝗗𝘂𝗮𝗹 𝗦𝗲𝗾𝘂𝗲𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗛𝘆𝗽𝗼𝘁𝗵𝗲𝘀𝗶𝘀 (𝗗𝗦𝗛).

𝗙𝗼𝗿 𝘆𝗲𝗮𝗿𝘀, 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗵𝗮𝘀 𝘃𝗶𝗲𝘄𝗲𝗱 𝗮𝗺𝘆𝗹𝗼𝗶𝗱 𝗽𝗹𝗮𝗾𝘂𝗲𝘀 𝗮𝗻𝗱 𝘁𝗮𝘂 𝘁𝗮𝗻𝗴𝗹𝗲𝘀 𝗮𝘀 𝘁𝗵𝗲 𝗽𝗿𝗶𝗺𝗮𝗿𝘆 𝘃𝗶𝗹𝗹𝗮𝗶𝗻𝘀 𝗶𝗻 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀. 𝗕𝘂𝘁 𝗱𝗲𝘀𝗽𝗶𝘁𝗲 𝗱𝗿𝘂𝗴𝘀 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹𝗹𝘆 𝗰𝗹𝗲𝗮𝗿𝗶𝗻𝗴 𝘁𝗵𝗲𝗺 𝗮𝘄𝗮𝘆, 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗼𝗳𝘁𝗲𝗻 𝗱𝗼𝗻’𝘁 𝗴𝗲𝘁 𝗯𝗲𝘁𝘁𝗲𝗿.

𝗢𝘂𝗿 𝗽𝗮𝗽𝗲𝗿 𝘀𝘂𝗴𝗴𝗲𝘀𝘁𝘀 𝗮 𝗻𝗲𝘄 𝗻𝗮𝗿𝗿𝗮𝘁𝗶𝘃𝗲:

𝗧𝗵𝗲 𝗕𝗿𝗮𝗶𝗻’𝘀 𝗟𝗼𝗰𝗸𝗯𝗼𝘅: 𝗔𝗺𝘆𝗹𝗼𝗶𝗱 𝗮𝗻𝗱 𝘁𝗮𝘂 𝗮𝗿𝗲 𝗮𝗰𝘁𝘂𝗮𝗹𝗹𝘆 𝗽𝗮𝗿𝘁 𝗼𝗳 𝗮𝗻 𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗮𝗿𝘆 𝗱𝗲𝗳𝗲𝗻𝘀𝗲 𝘀𝘆𝘀𝘁𝗲𝗺 𝗱𝗲𝘀𝗶𝗴𝗻𝗲𝗱 𝘁𝗼 𝗶𝘀𝗼𝗹𝗮𝘁𝗲 𝘁𝗵𝗿𝗲𝗮𝘁𝘀.

𝗧𝗵𝗲 𝗜𝗻𝗱𝗲𝘀𝘁𝗿𝘂𝗰𝘁𝗶𝗯𝗹𝗲 𝗧𝗿𝗶𝗴𝗴𝗲𝗿: 𝗣𝗲𝗿𝘃𝗮𝘀𝗶𝘃𝗲, 𝗺𝗶𝗰𝗿𝗼𝘀𝗰𝗼𝗽𝗶𝗰 𝗻𝗮𝗻𝗼𝗽𝗹𝗮𝘀𝘁𝗶𝗰𝘀 𝗮𝗰𝘁 𝗮𝘀 𝗽𝗲𝗿𝗺𝗮𝗻𝗲𝗻𝘁 𝗳𝗼𝗿𝗲𝗶𝗴𝗻 𝘀𝗲𝗲𝗱𝘀, 𝗵𝗶𝗷𝗮𝗰𝗸𝗶𝗻𝗴 𝘁𝗵𝗶𝘀 𝗱𝗲𝗳𝗲𝗻𝘀𝗲 𝗺𝗲𝗰𝗵𝗮𝗻𝗶𝘀𝗺 𝗮𝗻𝗱 𝗳𝗼𝗿𝗰𝗶𝗻𝗴 𝘁𝗵𝗲 𝗯𝗿𝗮𝗶𝗻 𝗶𝗻𝘁𝗼 𝗮 𝘀𝘁𝗮𝘁𝗲 𝗼𝗳 𝗽𝗲𝗿𝗺𝗮𝗻𝗲𝗻𝘁, 𝗳𝗿𝘂𝘀𝘁𝗿𝗮𝘁𝗲𝗱 𝗶𝗺𝗺𝘂𝗻𝗲 𝗿𝗲𝘀𝗽𝗼𝗻𝘀𝗲.

𝗧𝗵𝗲 𝗛𝗶𝗱𝗱𝗲𝗻 𝗘𝗻𝗲𝗺𝘆: 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝗱𝗿𝘂𝗴𝘀 𝗿𝗲𝗺𝗼𝘃𝗲 𝘁𝗵𝗲 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗱𝗲𝗳𝗲𝗻𝘀𝗲 𝘄𝗮𝗹𝗹, 𝗯𝘂𝘁 𝘁𝗵𝗲𝘆 𝗰𝗮𝗻’𝘁 𝗱𝗶𝘀𝘀𝗼𝗹𝘃𝗲 𝘁𝗵𝗲 𝘀𝘆𝗻𝘁𝗵𝗲𝘁𝗶𝗰 𝗽𝗹𝗮𝘀𝘁𝗶𝗰 𝗰𝗼𝗿𝗲 𝗵𝗶𝗱𝗶𝗻𝗴 𝗶𝗻𝘀𝗶𝗱𝗲 𝗶𝘁.

𝗧𝗵𝗶𝘀 𝗵𝘆𝗽𝗼𝘁𝗵𝗲𝘀𝗶𝘀 𝗰𝗮𝗹𝗹𝘀 𝗳𝗼𝗿 𝗮𝗻 𝘂𝗿𝗴𝗲𝗻𝘁 𝘀𝗵𝗶𝗳𝘁 𝗶𝗻 𝗵𝗼𝘄 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹𝘀 𝗮𝗻𝗱 𝗻𝗲𝘂𝗿𝗼𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝗶𝘀𝘁𝘀 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗲 𝗯𝗿𝗮𝗶𝗻 𝘁𝗶𝘀𝘀𝘂𝗲, 𝗽𝗿𝗼𝘃𝗶𝗻𝗴 𝘁𝗵𝗮𝘁 𝗺𝗼𝗱𝗲𝗿𝗻 𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁𝗮𝗹 𝗳𝗮𝗰𝘁𝗼𝗿𝘀 𝗰𝗮𝗻 𝗰𝗼𝗺𝗽𝗹𝗲𝘁𝗲𝗹𝘆 𝗱𝗶𝘀𝗿𝘂𝗽𝘁 𝗰𝗹𝗮𝘀𝘀𝗶𝗰𝗮𝗹 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝘀𝘆𝘀𝘁𝗲𝗺𝘀.

𝗜𝗳 𝘄𝗲 𝘄𝗮𝗻𝘁 𝘁𝗼 𝗰𝘂𝗿𝗲 𝘁𝗵𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀 𝗼𝗳 𝘁𝗼𝗺𝗼𝗿𝗿𝗼𝘄, 𝘄𝗲 𝗵𝗮𝘃𝗲 𝘁𝗼 𝘀𝘁𝗼𝗽 𝘂𝘀𝗶𝗻𝗴 𝘁𝗵𝗲 𝗽𝗮𝗿𝗮𝗱𝗶𝗴𝗺𝘀 𝗼𝗳 𝘆𝗲𝘀𝘁𝗲𝗿𝗱𝗮𝘆.

𝗗𝗶𝘃𝗲 𝗶𝗻𝘁𝗼 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝘀𝘁𝘂𝗱𝘆 𝗯𝗲𝗹𝗼𝘄: https://ejournals.uni-muenster.de/fnp/article/view/9368/9665

𝗝𝗼𝘂𝗿𝗻𝗮𝗹: 𝗙𝗿𝗲𝗲 𝗡𝗲𝘂𝗿𝗼𝗽𝗮𝘁𝗵𝗼𝗹. 𝟮𝟬𝟮𝟲 𝗝𝘂𝗻 𝟮𝟮;𝟳:𝟭𝟰.

𝗗𝗢𝗜: 𝟭𝟬.𝟭𝟳𝟴𝟳𝟵/𝗳𝗿𝗲𝗲𝗻𝗲𝘂𝗿𝗼𝗽𝗮𝘁𝗵𝗼𝗹𝗼𝗴𝘆-𝟮𝟬𝟮𝟲-𝟵𝟯𝟲𝟴.

#𝗘𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁𝗮𝗹𝗛𝗲𝗮𝗹𝘁𝗵 #𝗕𝗶𝗼𝘁𝗲𝗰𝗵 #𝗡𝗲𝘂𝗿𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲 #𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗮𝗯𝗶𝗹𝗶𝘁𝘆 #𝗠𝗲𝗱𝗶𝗰𝗮𝗹𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 #𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻

No alternative text description for this image

 

“𝗜𝗻𝘀𝗮𝗻𝗶𝘁𝘆 𝗶𝘀 𝗱𝗼𝗶𝗻𝗴 𝘁𝗵𝗲 𝘀𝗮𝗺𝗲 𝘁𝗵𝗶𝗻𝗴 𝗼𝘃𝗲𝗿 𝗮𝗻𝗱 𝗼𝘃𝗲𝗿 𝗮𝗴𝗮𝗶𝗻 𝗮𝗻𝗱 𝗲𝘅𝗽𝗲𝗰𝘁𝗶𝗻𝗴 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗿𝗲𝘀𝘂𝗹𝘁𝘀.” Alzheimer’s disease research!

“𝗜𝗻𝘀𝗮𝗻𝗶𝘁𝘆 𝗶𝘀 𝗱𝗼𝗶𝗻𝗴 𝘁𝗵𝗲 𝘀𝗮𝗺𝗲 𝘁𝗵𝗶𝗻𝗴 𝗼𝘃𝗲𝗿 𝗮𝗻𝗱 𝗼𝘃𝗲𝗿 𝗮𝗴𝗮𝗶𝗻 𝗮𝗻𝗱 𝗲𝘅𝗽𝗲𝗰𝘁𝗶𝗻𝗴 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗿𝗲𝘀𝘂𝗹𝘁𝘀.” 𝗙𝗼𝗿 𝗱𝗲𝗰𝗮𝗱𝗲𝘀, 𝘁𝗵𝗲 𝗯𝗶𝗼𝘁𝗲𝗰𝗵 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗵𝗮𝘀 𝗽𝗼𝘂𝗿𝗲𝗱 𝗯𝗶𝗹𝗹𝗶𝗼𝗻𝘀 𝗶𝗻𝘁𝗼 𝗮 𝘀𝗶𝗻𝗴𝘂𝗹𝗮𝗿 𝗴𝗼𝗮𝗹 𝗳𝗼𝗿 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲: 𝗰𝗹𝗲𝗮𝗿𝗶𝗻𝗴 𝗮𝗺𝘆𝗹𝗼𝗶𝗱 𝗽𝗹𝗮𝗾𝘂𝗲𝘀 𝗮𝗻𝗱 𝘁𝗮𝘂 𝘁𝗮𝗻𝗴𝗹𝗲𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗯𝗿𝗮𝗶𝗻. 𝗬𝗲𝘁, 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗮𝗳𝘁𝗲𝗿 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗵𝗮𝘀 𝗳𝗮𝗰𝗲𝗱 𝗱𝗶𝘀𝗮𝗽𝗽𝗼𝗶𝗻𝘁𝗶𝗻𝗴 𝗳𝗮𝗶𝗹𝘂𝗿𝗲𝘀. 𝗧𝗵𝗲 𝗽𝗹𝗮𝗾𝘂𝗲𝘀 𝗮𝗿𝗲 𝗿𝗲𝗺𝗼𝘃𝗲𝗱, 𝗯𝘂𝘁 𝘁𝗵𝗲 𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝘃𝗲 𝗱𝗲𝗰𝗹𝗶𝗻𝗲 𝗽𝗲𝗿𝘀𝗶𝘀𝘁𝘀.

𝗪𝗵𝘆 𝘁𝗵𝗲 𝗺𝗮𝘀𝘀𝗶𝘃𝗲 𝗱𝗶𝘀𝗰𝗼𝗻𝗻𝗲𝗰𝘁?

In my latest paper published this week in Free Neuropathology (June 2026), I propose a fundamental shift in how we view this disease: The Dual Sequestration Hypothesis (DSH).

What if these plaques and tangles aren’t the actual cause of the disease, but are instead the brain’s natural “defense structures” trying to trap an entirely different, hidden enemy?

In the modern “Plasticene” era, micro- and nanoplastics are entering our environments—and our bodies. Our research suggests these indestructible particles act as permanent seeds that hijack the brain’s immune system, creating a state of chronic “immune frustration.”

When we develop therapies that destroy the brain’s defense structures without removing the toxic plastic core underneath, we leave the true trigger behind. This explains both the therapeutic failures and common trial side effects like ARIA.

Solving the world’s toughest healthcare challenges requires stepping outside the consensus and looking at the intersection of environmental toxicology and classic pathology.

Read the full, open-access paper here: https://ejournals.uni-muenster.de/fnp/article/view/9368/9665

Journal: Free Neuropathol. 2026 Jun 22;7:14.
DOI: 10.17879/freeneuropathology-2026-9368.
PMID: 42344202.
#Biotech #HealthcareInnovation #AlzheimersResearch #ExecutiveLeadership #Pharmaceuticals #PublicHealth

 

View image

Alzheimer’s Dual Sequestration Hypothesis

𝐍𝐞𝐰 𝐏𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐅𝐫𝐞𝐞 𝐍𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 (𝐉𝐮𝐧𝐞 𝟐𝟎𝟐𝟔) 𝐈 𝐚𝐦 𝐩𝐥𝐞𝐚𝐬𝐞𝐝 𝐭𝐨 𝐬𝐡𝐚𝐫𝐞 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐜𝐥𝐢𝐧𝐢𝐜𝐨𝐩𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐮𝐩𝐝𝐚𝐭𝐞 𝐚𝐝𝐝𝐫𝐞𝐬𝐬𝐢𝐧𝐠 𝐚 𝐩𝐞𝐫𝐬𝐢𝐬𝐭𝐞𝐧𝐭 𝐩𝐚𝐫𝐚𝐝𝐨𝐱 𝐢𝐧 𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫’𝐬 𝐝𝐢𝐬𝐞𝐚𝐬𝐞: 𝐰𝐡𝐲 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 𝐭𝐚𝐫𝐠𝐞𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐫𝐞𝐦𝐨𝐯𝐚𝐥 𝐨𝐟 𝐚𝐦𝐲𝐥𝐨𝐢𝐝-β 𝐩𝐥𝐚𝐪𝐮𝐞𝐬 𝐚𝐧𝐝 𝐭𝐚𝐮 𝐭𝐚𝐧𝐠𝐥𝐞𝐬 𝐜𝐨𝐧𝐬𝐢𝐬𝐭𝐞𝐧𝐭𝐥𝐲 𝐬𝐡𝐨𝐰 𝐚 𝐜𝐫𝐢𝐭𝐢𝐜𝐚𝐥 𝐝𝐢𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐢𝐨𝐧 𝐟𝐫𝐨𝐦 𝐜𝐨𝐫𝐞 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐩𝐚𝐭𝐡𝐨𝐠𝐞𝐧𝐞𝐬𝐢𝐬.

𝐈𝐧 “𝐀𝐥𝐳𝐡𝐞𝐢𝐦𝐞𝐫’𝐬 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐥𝐚𝐬𝐭𝐢𝐜𝐞𝐧𝐞 𝐞𝐫𝐚: 𝐚 𝐜𝐥𝐢𝐧𝐢𝐜𝐨𝐩𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐮𝐩𝐝𝐚𝐭𝐞 𝐨𝐧 𝐭𝐡𝐞 𝐝𝐮𝐚𝐥 𝐬𝐞𝐪𝐮𝐞𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐚𝐦𝐲𝐥𝐨𝐢𝐝 𝐚𝐧𝐝 𝐭𝐚𝐮 𝐚𝐬 𝐡𝐢𝐣𝐚𝐜𝐤𝐞𝐝 𝐢𝐧𝐧𝐚𝐭𝐞 𝐢𝐦𝐦𝐮𝐧𝐞 𝐫𝐞𝐬𝐩𝐨𝐧𝐬𝐞𝐬,” 𝐰𝐞 𝐩𝐫𝐨𝐩𝐨𝐬𝐞 𝐭𝐡𝐞 𝐃𝐮𝐚𝐥 𝐒𝐞𝐪𝐮𝐞𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐇𝐲𝐩𝐨𝐭𝐡𝐞𝐬𝐢𝐬 (𝐃𝐒𝐇).

Key Frameworks Addressed:

The Sequestration Response: Reinterpreting Aβ and tau as conserved, compartment-specific innate immune barriers—an extracellular “sarcophagus” and an intracellular “lockbox.”

The Synthetic Trigger: How pervasive, indestructible environmental nanoplastics (NPs) act as permanent nucleation seeds, hijacking these responses into an indigestible synthetic protein complex.

Immune Frustration & Progression: Chronic microglial engagement triggers NLRP3 inflammasome activation, leading to pyroptotic cell death. This lytic release distributes intact synthetic seeds via glymphatic flow, physically obstructing clearance and driving Braak stage progression.

Therapeutic Relevance:
The DSH offers a structural explanation for the therapeutic failure of anti-Aβ/anti-tau antibodies (removing the biological barrier but leaving the synthetic core) and frames amyloid-related imaging abnormalities (ARIA) as an inflammatory rebound.

The paper calls for a necessary paradigm shift in neuropathological practice—specifically, utilizing novel detection techniques to visualize the predicted synthetic NP cores within classical lesions.

Full text and citation details below:

Journal: Free Neuropathol. 2026 Jun 22;7:14.

DOI: 10.17879/freeneuropathology-2026-9368

PMID: 42344202

hashtagAlzheimersDisease hashtagNeuropathology hashtagNeuroinflammation hashtagEnvironmentalToxicology hashtagBiopharma hashtagRWE

diagram

Book Review by Michael A. S. Guth: Outlaw (Battle Born #2) by Jack Stewart

Outlaw Outlaw by Jack Stewart

Book Review: Outlaw (Battle Born #2) by Jack Stewart

Narrated by Ray Porter Rating: 5/5 Stars

If you are looking for a military thriller that hits the ground running at Mach 2 and refuses to slow down, Jack Stewart’s Outlaw delivers on every front. The second installment in the Battle Born series masterfully escalates global stakes while keeping the action grounded in blistering tactical realism.

The Narrative: A High-Stakes Global Tightrope

The plot functions like a perfectly timed sequence of explosive charges. What starts as a high-stakes Navy SEAL rescue mission in China to recover a missing CIA case officer rapidly spirals into a multi-theater nightmare. Stewart does an exceptional job of intertwining high-altitude dogfights with granular, boots-on-the-ground tension when a devastating bioweapon enters the equation.

The introduction of the bioweapon targeting Colt Bancroft’s own aircraft carrier changes the geometry of the entire plot. It transforms the book from a standard military rescue mission into an existential race against a global catastrophe.

Characters and Chemistry

TOPGUN pilot Colt Bancroft remains a phenomenal protagonist—capable, sharp, and carrying the unique brand of grit required of a supersonic fighter pilot. Pairing him with NCIS Agent Emmy King is where the book’s human element shines. King is highly intelligent, driven, and brings a personal vendetta to the table that adds a layer of emotional weight to the tactical maneuvering. Their chemistry provides a grounded anchor to a plot that spans continents and threatens a third world war.

The Audio Production: Ray Porter Delivers a Masterclass

While Stewart’s writing is sharp and technically precise, Ray Porter’s narration elevates this audiobook into an absolute powerhouse. Porter proves once again why he is one of the premier voices in the thriller genre.

  • Pacing & Tension: Porter understands the cadence of a thriller. He knows exactly when to accelerate his delivery during an FA-18E Super Hornet dogfight to make your chest tighten, and when to drop into a calculated, measured tone during tense diplomatic or tactical standoffs.

  • Character Distinction: His ability to pivot between the distinct voices of hardened military operators, intelligence officers, and foreign adversaries keeps the listener fully immersed without a single moment of confusion.

Final Verdict

Outlaw is a brilliant combination of technical authenticity, relentless pacing, and stellar character work. For fans of military fiction and suspense, it checks every single box. Ray Porter’s narration turns a fantastic script into an unforgettable audio experience.

With the stakes left echoing at the end of book two, continuing the Battle Born series isn’t just a recommendation—it’s a necessity.

Diffuse Lewy Body Dementia in the Great Robin Williams

I have the deepest, most profound respect for Robin Williams. I wish it were more widely known, while he was still living, what a decent, caring, sympathetic person Robin Williams was. I just finished watching the documentary “Robin’s Wish” (available to stream on Plex and Tubi) and learned that the cause of death in the coroner’s report was not “suicide by hanging” but rather “Diffuse Lewy Body dementia.“ Robin Williams was at the mercy of a disease that he could not control and that he did not even know he had. His disease took control of his brain and his actions at the end. He knew something was wrong with his brain, and yet brain scans in 2013 and 2014 revealed nothing.

The devastation to Robin Williams’ brain was one of the worst cases medical professionals had ever seen. When I saw words like alpha-synuclein proteinopathy found in the substantia nigra and occipital cortex, insular cortex, temporal cortex; these are the very same protein pathologies and regions of the brain that I describe in my 2026 journal articles. How could they go undetected until his autopsy?

Robin Williams’ Lewy Body Dementia (LBD) went undetected on brain scans in 2013 and 2014 because standard structural imaging (like structural MRIs or CT scans) generally look for visible tumors, strokes, or major atrophy, rather than the microscopic protein deposits that cause LBD.

The specific limitations of medical technology and the nature of the disease at the time included:

Microscopic Pathology: LBD is caused by a microscopic buildup of abnormal proteins, known as Lewy bodies, inside the brain’s nerve cells. These deposits alter brain chemistry and circuitry rather than causing large-scale structural damage. Because the changes are at the cellular level, they are invisible on standard structural scans.

No Diagnostic Biomarker: During his life, there were no specific, widely accepted blood tests, spinal taps, or highly accurate brain-imaging biomarkers available to detect LBD. A definitive diagnosis could only be confirmed post-mortem through a brain autopsy.

Symptom Mimicry: LBD symptoms—which include severe anxiety, paranoia, hallucinations, and sleep disturbances—are widespread and strongly mimic Alzheimer’s disease, Parkinson’s disease, and psychiatric disorders. Williams was initially diagnosed with and treated for Parkinson’s disease, as he suffered from physical symptoms like a shuffling gait and tremors.

Symptom Fluctuation: The cognitive and psychiatric symptoms of LBD can come and go. Because a patient can seem entirely lucid for periods and can “pull themselves together,” medical professionals often misattribute the initial cognitive lapses to stress, fatigue, or depression rather than an irreversible neurodegenerative disease.

Ultimately, pathologists discovered during his autopsy that Williams had one of the most severe and diffuse cases of LBD they had ever seen.

https://www.goodgoodgood.co/articles/robin-williams-charity-work-death-anniversary
Robin Williams sitting next to a homeless man.

𝐂𝐚𝐧 𝐭𝐡𝐞 𝐔𝐒 𝐁𝐞𝐜𝐨𝐦𝐞 𝐚 𝐓𝐡𝐢𝐫𝐝 𝐖𝐨𝐫𝐥𝐝 𝐂𝐨𝐮𝐧𝐭𝐫𝐲? 𝐓𝐡𝐞 𝐃𝐫𝐢𝐩, 𝐃𝐫𝐢𝐩, 𝐃𝐫𝐢𝐩 𝐨𝐟 𝐃𝐞𝐜𝐥𝐢𝐧𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞.

Health insurance coverage in the USA is declining, driven by the expiration of enhanced Affordable Care Act (ACA) subsidies and post-pandemic Medicaid unwinding. Millions are dropping out of the market due to unaffordable premiums, while those who retain plans face narrower networks, stricter coverage denials, and higher out-of-pocket costs.

The decline in US health insurance coverage is a multi-layered crisis defined by three core issues:

Expiration of ACA Subsidies: The termination of enhanced premium tax credits caused premiums to skyrocket for millions. Consequently, an estimated 5 million customers are projected to exit the ACA marketplaces, with significant drops in monthly enrollment already being tracked state-by-state.

Medicaid Unwinding: The end of pandemic-era continuous enrollment rules resulted in massive Medicaid disenrollment, driving the first increase in the uninsured rate in recent years.

Rising Employer Costs: The soaring cost of employer-sponsored plans (averaging roughly $27,000 annually for families) has caused the percentage of small firms offering health benefits to drop. Meanwhile, approximately one in five privately insured adults reports coverage denials for doctor-recommended care.

You can track the state-by-state breakdowns of these changes using the KFF Uninsured Population Report or explore the Commonwealth Fund 2025 Affordability Survey regarding denied care.

timeline